(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:
Chronic Pain
This study will evaluate the safety and effectiveness of Kadian NT when taken for chronic pain over a period of up to one year. Volunteers 18-70 with a history of chronic moderate-to-severe pain for at least three months may qualify.
The research sites are located across the United States.
More information
Please see http://www.centerwatch.com/patient/studies/cat45.html.
-----
Diabetes - Type 2
This study will evaluate an experimental tablet (NN4440), containing two commonly used diabetes drugs (metformin and repaglinide), and how it controls glucose levels when given twice daily versus three times daily. Candidates at least 18 who have been diagnosed with type 2 diabetes for at least three months and are currently on one or two diabetes drugs may be eligible. Other criteria apply.
The research sites are located across the United States.
More information
Please see http://www.centerwatch.com/patient/studies/cat603.html.
-----
Depression
If you're a woman 18-65 who has symptoms of depression -- such as feeling sad, having trouble sleeping, or not enjoying life the way you once did -- you may be eligible for this study of an investigational medication.
The research sites are located across the United States.
More information
Please see http://www.centerwatch.com/patient/studies/cat164.html.
-----
Copyright 2006 Thomson CenterWatch. All rights reserved.
